KALA BIO
KALA
21 hedge funds and large institutions have $4.81M invested in KALA BIO in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
0.13% less ownership
Funds ownership: 0.44% → 0.31% (-0.13%)
25% less funds holding
Funds holding: 28 → 21 (-7)
63% less capital invested
Capital invested by funds: $12.8M → $4.81M (-$8.01M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $361K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.18M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$285K |
| 3 |
BlackRock
New York
|
+$99.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$27.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$15.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
-$1.88M |
| 2 |
Renaissance Technologies
New York
|
-$404K |
| 3 |
State Street
Boston,
Massachusetts
|
-$381K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$340K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$249K |
KALA Hedge Fund Activity: Q1 2023 in Review
21 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2023, worth a combined $4.81M — down 63% from $12.8M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of KALA and 0 opened new positions — a net loss of 7 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was Millennium Management, adding an estimated $1.18M. The largest seller was Clear Street, exiting entirely with an estimated $1.88M sold.
- 21 institutional investors held KALA BIO (KALA) as of Q1 2023, down from 28 in Q4 2022.
- Funds reported $4.81M of KALA BIO stock for Q1 2023, down 63% quarter-over-quarter.
- 0 funds opened new KALA BIO positions in Q1 2023 and 7 closed out, a net change of -7 holders.
- The largest KALA BIO buyer in Q1 2023 was Millennium Management, an estimated $1.18M added.
- The largest KALA BIO seller in Q1 2023 was Clear Street, an estimated $1.88M sold.
Based on aggregated 13F filings for Q1 2023.